Nicolas Ferreyros, managing director at Community Oncology Alliance (COA), discusses the recent Senate commerce hearing on pharmacy benefit managers (PBMs), which brought bipartisan attention and energy towards addressing the concerns related to PBMs in Washington.
While the outcome of the ongoing Federal Trade Commission (FTC) investigation on pharmacy benefit managers (PBMs) is uncertain, there are other developments in Congress that indicate movement towards reform, says Nicolas Ferreyros, managing director, Community Oncology Alliance.
Transcript
What do you think were the most important takeaways from the latest Senate hearing on PBMs?
The biggest takeaway from the Senate commerce hearing on pharmacy benefit managers is that it is now a front and center bipartisan issue. What we are hearing in Washington, “Okay, they've passed the inflation Reduction Act, they've tackled negotiation, and Medicare.” And so, they think that maybe there's a win in the column for drug prices. But, you know, there's still that 800-pound gorilla in the room of pharmacy benefit managers that they need to tackle. And if nothing out of that hearing was shown, it’s that there is bipartisan energy behind reform and investigation of PBMs.
Is there a timeline on the FTC investigation, and what should practices and individual doctors expect?
It's anybody's guess when the FTC investigation on PBMs is going to come out. We spent hours, I mean, countless hours on the phone with the FTC giving them information, putting them in contact with subject matter experts, practices, pharmacies, to learn about, sort of the dirty tricks that PBMs employ.
These types of investigations can be long and they can be bureaucratic; who's to say when they come out. But luckily, the FTC investigation is not the only thing happening in Washington. You have the Senate commerce hearing; you have a number of bills both in the Senate and in the House right now. There is movement on PBMs, and we're very hopeful this year that Congress is going to make something happen.
Frameworks for Advancing Health Equity: Urban Health Outreach
May 9th 2024In the series debut episode of "Frameworks for Advancing Health Equity," Mary Sligh, CRNP, and Chelsea Chappars, of Allegheny Health Network, explain how the Urban Health Outreach program aims to improve health equity for individuals experiencing homelessness.
Listen
CMS Medicare Final Rule: Advancing Benefits, Competition, and Consumer Protection
May 7th 2024On this episode of Managed Care Cast, we're talking with Karen Iapoce, senior director of government products and programs at ZeOmega, about the recent CMS final rule on Medicare Part D and Medicare Advantage.
Listen
Posters Characterize DMD Caregiver Experiences, Impact of Gene Therapy on Caregiving Demands
May 10th 2024Posters presented at the ISPOR—The Professional Society for Health Economics and Outcomes Research meeting explored Duchenne muscular dystrophy (DMD) caregiver experiences and gene therapy’s impact on work opportunities for caregivers.
Read More
A Focus on Women: AUA Best Posters Highlight Female Athletes, Prenatal Care, and Women in Urology
May 9th 2024Three posters from the American Urological Association (AUA) 2024 Annual Meeting focused on urinary incontinence in female athletes, prenatal care for fetuses with spina bifida in California, and the experiences of women residents at the Brady Urological Institute.
Read More